References
- Carpinello, S. E., Knight, E. L., & Markowitz, F. E. (2000). The development of the mental health confidence scale: A measure of self-efficacy in individuals diagnosed with mental disorders. Psychiatric Rehabilitation Journal, 23, 236–243. doi: 10.1037/h0095162
- De Leon, G., Melnick, G., Kressel, D., & Jainchill, N. (1994). Circumstances, motivation, readiness, and suitability (the CMRS scales): Predicting retention in therapeutic community treatment. The American Journal of Drug Alcohol Abuse, 20, 495–515. doi: 10.3109/00952999409109186
- Drake, R. E., & Brunette, M. F. (1998). Complications of severe mental illness related to alcohol and drug use disorders. Recent Developments in Alcoholism, 14, 285–299.
- Emotional Health Anonymous. (2007). Frequently asked questions. Retrieved May 1, 2012, from http://emotionalhealthanonymous.org
- Hoge, S. K., Appelbaum, P. S., Lawlor, T., Beck, J. C., Litman, R., Greer, A., … Kaplan, E. (1990). A prospective, multicenter study of patients’ refusal of antipsychotic medication. Archives of General Psychiatry, 47, 949–956. doi: 10.1001/archpsyc.1990.01810220065008
- Julius, R. J., Novitsky, M. A. Jr., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15, 34–44. doi: 10.1097/01.pra.0000344917.43780.77
- Kessler, R. C. (1995). The national comorbidity survey: Preliminary results and future directions. International Journal of Methods in Psychiatric Research, 5, 139–151.
- Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892–909. doi: 10.4088/JCP.v63n1007
- Laudet, A., Magura, S., Vogel, H., & Knight, E. (2000). Support, mutual aid and recovery from dual diagnosis. Community Mental Health Journal, 36, 457–476. doi: 10.1023/A:1001982829359
- Lin, J., Wong, B., Offord, S., & Mirski, D. (2013). Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophrenia. The Journal of Behavioral Health Services & Research, 40, 355–366. doi: 10.1007/s11414-013-9329-z
- Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105, 164–172. doi: 10.1034/j.1600-0447.2002.1r084.x
- Magura, S., Laudet, A., Mahmood, D., Rosenblum, A., & Knight, E. (2002). Medication adherence and participation in self-help groups designed for dually-diagnosed persons. Psychiatric Services, 53, 310–316. doi: 10.1176/appi.ps.53.3.310
- Magura, S., Rosenblum, A., & Fong, C. (2011). Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. Open Addiction Journal, 4, 58–64. doi: 10.2174/1874941001104010058 doi: 10.2174/1874941001104010058
- Magura, S., Rosenblum, A., Villano, C., Vogel, H. S., Fong, C., & Betzler, T. (2008). Mutual aid for co-occurring disorders: A quasi-experimental outcome study. The American Journal of Drug and Alcohol Abuse, 34(1), 61–74. doi: 10.1080/00952990701764623
- Magura, S., Villano, C. L., Rosenblum, A., Vogel, H. S., & Betzler, T. (2008). Consumer evaluation of dual focus mutual aid. Journal of Dual Diagnosis, 4(2), 170–185. doi: 10.1080/15504260802067032
- Martin, G. W., Wilkinson, D. A., & Poulos, C. X. (1995). The Drug Avoidance Self-Efficacy Scale. Journal of Substance Abuse, 7, 151–163. doi: 10.1016/0899-3289(95)90001-2
- Miller, W. R., & Rollnick, S. (2012). Motivational interviewing, third edition: Helping people change. New York, NY: Guilford.
- Murphy, J. M. (1990). Diagnostic comorbidity and symptom co-occurrence: The Stirling County Study. In J. D. Maser & C. R. Cloninger (Eds.), Comorbidity of mood and anxiety disorders (pp. 153–176). Washington, DC: American Psychiatric Press.
- Noordsy, D., Schwab, B., Fox, L., & Drake, R. (1996). The role of self-help programs in the rehabilitation process of persons with severe mental illness and substance use disorders. Community Mental Health Journal, 32, 71–81. doi: 10.1007/BF02249369
- Nosé, M., Barbui, C., & Tansella, M. (2003). How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine, 33, 1149–1160. doi: 10.1017/S0033291703008328
- Offord, S., Lin, J., Mirski, D., & Wong, B. (2013). Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia. Advances in Therapy, 30(3), 286–297. doi: 10.1007/s12325-013-0016-5
- Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., Lieberman, J. A., & Comparison of Atypicals in First Episode Study Group. (2008). Predictors of treatment discontinuation and medication adherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder or schizoaffective disorder: A randomized, double-blind, flexible dose, multicenter study. Journal of Clinical Psychiatry, 69, 106–113. doi: 10.4088/JCP.v69n0114
- Prochaska, J. O., & DiClemente, C. C. (1992). Stages of change in the modification of problem behaviors. Progress in Behavior Modification, 28, 183–218.
- Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short “readiness to change” questionnaire for use in brief opportunistic interventions among excessive drinkers. British Journal of Addictions, 87, 743–754. doi: 10.1111/j.1360-0443.1992.tb02720.x
- Rosen, C. S., Drescher, K. D., Moos, R. H., Finney, J. W., Murphy, R. T., & Gusman, F. (2000). Six and ten-item indexes of psychological distress based on the Symptom Checklist-90. Assessment, 7, 103–111. doi: 10.1177/107319110000700201
- Rosenblum, A., Magura, S., Laudet, A. B., & Vogel, H. (2011). Mutual aid groups. In D. B. Cooper (Ed.), Intervention in mental health – substance use (pp. 207–224). New York, NY: Radcliffe.
- Ruscher, S. M., de Wit, R., & Mazmanian, D. (1997). Psychiatric patients’ attitudes about medication and factors affecting noncompliance. Psychiatric Services, 48, 82–85.
- Sowers, W., & Golden, S. (1999). Psychotropic medication management in persons with co-occurring psychiatric and substance abuse disorders. Journal of Psychoactive Drugs, 3, 59–70. doi: 10.1080/02791072.1999.10471727
- Substance Abuse and Mental Health Services Administration. (2012). National survey on drug use and health, 2009. Retrieved March 30, 2012, from http://www.oas.samhsa.gov/NSDUH/2k9NSDUH/MH/tabs/Sect1peMHtabs.htm#Tab1.10B
- Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42, 241–247. doi: 10.1016/S0920-9964(99)00130-9
- Trivedi, M. H., Lin, E. H., & Katon, W. J. (2007). Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectrums, 12(8, Suppl 13), 1–27.
- Vogel, H. S., Knight, E. L., Laudet, A. B., & Magura, S. (1998). Double Trouble in Recovery: Self-help for the dually-diagnosed. Psychiatric Rehabilitation Journal, 21, 356–364. doi: 10.1037/h0095288
- Weiss, R. D. (2004). Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction, 99(11), 1382–1392. doi: 10.1111/j.1360-0443.2004.00884.x
- Weiss, R. D., Greenfield, S. F., Najavits, L. M., Soto, J. A., Wyner, D., Tohen, M., & Griffin, M. L. (1998). Medication compliance among patients with bipolar disorder and substance use disorder. Journal of Clinical Psychiatry, 59, 172–174. doi: 10.4088/JCP.v59n0405
- Zeber, J. E., Miller, A. L., Copeland, L. A., McCarthy, J. F., Zivin, K., Valenstein, M., … Kilbourne, A. M. (2011). Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Administration and Policy in Mental Health, 38, 86–95. doi: 10.1007/s10488-010-0304-1